NAFDAC Bans Mars Remedies PVT Limited from Manufacturing Counterfeit Medicines
The Indian company was banned in Nigeria by the National Food and Drug Administration (NAFDAC).
India has been banned from manufacturing counterfeit drugs for a pharmaceutical company in Nigeria, according to Mars Remedies PVT Limited.
The agency reported this in a statement signed Tuesday in Abuja by its director general, prof. Mojisola Adeyeye.
Adeyay said that all products manufactured by Mars Remedies PVT, 635, GIDC Estate Waghodia Vadodara, Gujarat, India, were immediately banned from entry into Nigeria due to unprofessional practices.
According to her, the agency categorically does not accept low-quality products.
The CEO also revealed that the agency has also blacklisted the NAFDAC C4-0498 500mg ciprofloxacin BP tablets that were manufactured for Pinnacle Health Pharmaceutical, Surulere, Lagos.
“In violation of existing NAFDAC laws and regulations, the company illegally manufactured several formulations of ciprofloxacin tablets instead of a formulation approved for export to Nigeria.
“Changes to the formulation of Ciprofloxacin 500 mg tablets, which may affect product quality and shelf life, were not approved by the agency prior to these changes.
“This is a violation of NAFDAC law.
“The company has demonstrated a clear disregard for global standards necessary to ensure the production of quality products.”